Biocon Limited
NSE:BIOCON.NS
321.3 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 147,557 | 111,742 | 80,248 | 69,701 | 62,115 | 53,811 | 39,781 | 38,458 | 34,050 | 30,592 | 28,513 | 24,263 | 20,490 | 23,005.21 | 20,363.62 | 13,718.485 | 8,334.042 | 8,227.531 | 6,874.924 | 6,463.624 | 5,018.824 |
| Cost of Revenue
| 90,470 | 36,631 | 27,236 | 22,102 | 20,543 | 18,989 | 16,383 | 14,486 | 13,325 | 12,584 | 11,886 | 10,461 | 8,532 | 21,840.144 | 11,714.117 | 8,384.43 | 4,647.852 | 4,507.698 | 4,001.539 | 3,577.181 | 2,637.784 |
| Gross Profit
| 57,087 | 75,111 | 53,012 | 47,599 | 41,572 | 34,822 | 23,398 | 23,972 | 20,725 | 18,008 | 16,627 | 13,802 | 11,958 | 1,165.066 | 8,649.503 | 5,334.055 | 3,686.19 | 3,719.833 | 2,873.385 | 2,886.443 | 2,381.04 |
| Gross Profit Ratio
| 0.387 | 0.672 | 0.661 | 0.683 | 0.669 | 0.647 | 0.588 | 0.623 | 0.609 | 0.589 | 0.583 | 0.569 | 0.584 | 0.051 | 0.425 | 0.389 | 0.442 | 0.452 | 0.418 | 0.447 | 0.474 |
| Reseach & Development Expenses
| 838 | 6,132 | 5,028 | 3,950 | 3,077 | 1,396 | 358 | 1,492 | 2,743 | 2,000 | 1,329 | 1,067 | 967 | 0 | 0 | 0 | 144.492 | 168.743 | 0 | 0 | 0 |
| General & Administrative Expenses
| 37,918 | 2,651 | 1,869 | 2,529 | 1,513 | 1,167 | 1,031 | 709 | 703 | 852 | 568 | 599 | 472 | 0 | 4,798.553 | 1,351.911 | 1,448.622 | 1,128.614 | 643.251 | 550.145 | 437.945 |
| Selling & Marketing Expenses
| 1,870 | 2,216 | 2,438 | 2,340 | 2,703 | 2,775 | 982 | 1,074 | 1,139 | 1,087 | 1,189 | 996 | 874 | 0 | 0 | 652.09 | 399.939 | 272.147 | 196.454 | 158.446 | 103.684 |
| SG&A
| 39,788 | 4,867 | 4,307 | 4,869 | 4,216 | 3,942 | 2,013 | 1,783 | 1,842 | 1,939 | 1,757 | 1,595 | 1,346 | 0 | 4,798.553 | 2,004.001 | 1,848.561 | 1,400.761 | 839.705 | 708.591 | 541.629 |
| Other Expenses
| 9,493 | 7,681 | 4,771 | 3,572 | 3,508 | 2,738 | 1,927 | 1,412 | 1,512 | 1,492 | 1,819 | 116 | 124 | 429.29 | 167.288 | 714.279 | -326.6 | 33.803 | 7.324 | 25.3 | 205.692 |
| Operating Expenses
| 39,788 | 65,047 | 45,911 | 41,552 | 34,507 | 28,021 | 20,701 | 18,203 | 16,131 | 14,381 | 13,095 | 9,856 | 8,522 | -3,134.355 | 4,965.841 | 2,718.28 | 1,666.453 | 1,603.307 | 847.029 | 733.891 | 747.321 |
| Operating Income
| 17,299 | 15,643 | 11,583 | 9,539 | 10,520 | 9,459 | 2,697 | 5,769 | 4,594 | 3,627 | 3,532 | 3,946 | 3,436 | 4,299.421 | 3,683.662 | 2,615.775 | 2,019.737 | 2,116.526 | 2,026.356 | 2,152.552 | 1,633.719 |
| Operating Income Ratio
| 0.117 | 0.14 | 0.144 | 0.137 | 0.169 | 0.176 | 0.068 | 0.15 | 0.135 | 0.119 | 0.124 | 0.163 | 0.168 | 0.187 | 0.181 | 0.191 | 0.242 | 0.257 | 0.295 | 0.333 | 0.326 |
| Total Other Income Expenses Net
| -1,205 | -6,672 | -1,752 | 1,138 | 1,629 | 2,690 | 3,403 | 2,728 | 7,680 | 2,614 | 1,845 | 2,156 | 489 | 172.268 | -168.92 | -15.784 | 289.357 | -6.558 | -0.867 | -1.449 | -17.008 |
| Income Before Tax
| 16,094 | 8,971 | 9,831 | 10,774 | 11,860 | 12,149 | 6,100 | 8,497 | 12,274 | 6,241 | 5,377 | 6,102 | 3,925 | 4,471.689 | 3,514.742 | 2,599.991 | 2,309.094 | 2,109.968 | 2,025.489 | 2,151.103 | 1,616.711 |
| Income Before Tax Ratio
| 0.109 | 0.08 | 0.123 | 0.155 | 0.191 | 0.226 | 0.153 | 0.221 | 0.36 | 0.204 | 0.189 | 0.251 | 0.192 | 0.194 | 0.173 | 0.19 | 0.277 | 0.256 | 0.295 | 0.333 | 0.322 |
| Income Tax Expense
| 2,274 | 2,541 | 2,115 | 2,215 | 3,151 | 2,123 | 1,569 | 1,616 | 2,569 | 957 | 1,069 | 975 | 541 | 721.207 | 486.681 | 118.384 | 128.883 | 169.119 | 305.654 | 186.067 | 230.342 |
| Net Income
| 10,225 | 4,627 | 6,484 | 7,405 | 7,482 | 9,053 | 3,724 | 6,121 | 8,961 | 4,974 | 4,138 | 5,089 | 3,384 | 3,675.15 | 2,932.442 | 931.217 | 4,639.094 | 2,002.616 | 1,739.523 | 1,975.45 | 1,386.362 |
| Net Income Ratio
| 0.069 | 0.041 | 0.081 | 0.106 | 0.12 | 0.168 | 0.094 | 0.159 | 0.263 | 0.163 | 0.145 | 0.21 | 0.165 | 0.16 | 0.144 | 0.068 | 0.557 | 0.243 | 0.253 | 0.306 | 0.276 |
| EPS
| 8.55 | 3.88 | 5.44 | 6.24 | 6.32 | 7.65 | 3.16 | 5.2 | 4.67 | 4.14 | 3.52 | 4.33 | 2.88 | 3.13 | 2.51 | 0.81 | 4 | 1.79 | 1.52 | 1.74 | 1.36 |
| EPS Diluted
| 8.54 | 3.87 | 5.42 | 6.19 | 6.3 | 7.6 | 3.14 | 5.16 | 4.67 | 4.14 | 3.47 | 4.29 | 2.85 | 3.1 | 2.47 | 0.78 | 3.88 | 1.78 | 1.5 | 1.7 | 1.33 |
| EBITDA
| 32,987 | 27,206 | 19,645 | 16,756 | 17,283 | 15,211 | 9,971 | 11,364 | 8,931 | 7,410 | 7,417 | 5,944 | 5,741 | 6,296.458 | 5,085.063 | 3,741.277 | 578.159 | 2,793.385 | 2,336.434 | 2,400.842 | 1,834.32 |
| EBITDA Ratio
| 0.224 | 0.243 | 0.245 | 0.24 | 0.278 | 0.283 | 0.251 | 0.295 | 0.262 | 0.242 | 0.26 | 0.245 | 0.28 | 0.274 | 0.25 | 0.273 | 0.069 | 0.34 | 0.34 | 0.371 | 0.365 |